Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.78 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.78 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.78 |
| ▸ | AR | P10275 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | USP2 | O75604 | 1/20 | 0.78 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.78 |
| ▸ | ESR1 | P03372 | 1/20 | 0.78 |
| ▸ | TST | Q16762 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | SREBF1 | P36956 | 1/20 | 0.68 |
| ▸ | VDR | P11473 | 4/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 25-Hydroxyergocalciferol- SCHEMBL15981129 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL19469428 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL15981131 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL10034123 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL285346 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL465799 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL12464610 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL17274134 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL1879846 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 | |
| 25-Hydroxyergocalciferol- SCHEMBL9933381 | 1.00 | ALDH1A1 (0.78) | ALDH1A1ALOX15CYP3A4LMNAHSPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2768804-B1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RES FOUND (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-2768803-B1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RES FOUND (US) | 2017-11-22 | — | — | EP | disclosed |
| EP-2721004-B1 | 3-DESOXY-2-METHYLENE-19-NOR-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RES FOUND (US) | 2017-07-26 | — | — | EP | disclosed |
| US-8993547-B2 | 3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-03-31 | — | — | US | disclosed |
| EP-2768803-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | Wisconsin Alumni Research Foundation (US) | 2014-08-27 | — | — | EP | disclosed |
| EP-2768804-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | Wisconsin Alumni Research Foundation (US) | 2014-08-27 | — | — | EP | disclosed |
| US-8785422-B2 | A-ring modified 19-nor-vitamin D analogs and their uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-07-22 | — | — | US | disclosed |
| US-8729054-B2 | 3-desoxy-2-methylene-vitamin D analogs and their uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-05-20 | — | — | US | disclosed |
| EP-2721004-A1 | 3-DESOXY-2-METHYLENE-19-NOR-VITAMIN D ANALOGS AND THEIR USES | Wisconsin Alumni Research Foundation (US) | 2014-04-23 | — | — | EP | disclosed |
| US-20130331459-A1 | A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-12-12 | — | — | US | disclosed |
| US-8455467-B2 | 2-methylene-vitamin D analogs and their uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-06-04 | — | — | US | disclosed |
| WO-2013059021-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-04-25 | — | — | WO | disclosed |
| US-20130102574-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-04-25 | — | — | US | disclosed |
| WO-2013059060-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSON ALUMNI RESEARCH FOUNDATION (US) | 2013-04-25 | — | — | WO | disclosed |
| US-20130102573-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-04-25 | — | — | US | disclosed |
| US-20130102567-A1 | 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-04-25 | — | — | US | disclosed |
| US-8410080-B1 | 2-methylene-vitamin D analogs and their uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-04-02 | — | — | US | disclosed |
| US-20120322775-A1 | 3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-12-20 | — | — | US | disclosed |
| WO-2012174095-A1 | 3-DESOXY-2-METHYLENE-19-NOR-VITAMIN D ANALOGS AND THEIR USES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-12-20 | — | — | WO | disclosed |
| US-20120157418-A1 | 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102567-A1 | 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses | VDR, CYP24A1, CYP2R1 | ALDH1A1 479/4885ALOX15 710/4885CYP3A4 982/4885 |
| US-20130102574-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | CYP24A1, VDR, CYP27B1 | ALDH1A1 142/4885ALOX15 743/4885CYP3A4 1007/4885 |
| US-20130331459-A1 | A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses | VDR, CYP24A1, CYP2R1 | ALDH1A1 2745/4885ALOX15 343/4885CYP3A4 918/4885 |
| US-20120157418-A1 | 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses | CYP24A1, CYP2R1, CYP27B1 | ALDH1A1 185/4885ALOX15 347/4885CYP3A4 178/4885 |
| US-20130102573-A1 | 2-METHYLENE-VITAMIN D ANALOGS AND THEIR USES | VDR, CYP24A1, CYP2R1 | ALDH1A1 291/4885ALOX15 626/4885CYP3A4 1232/4885 |
| US-20120322775-A1 | 3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses | VDR, CYP24A1, CYP2R1 | ALDH1A1 458/4885ALOX15 321/4885CYP3A4 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.